Carregant...

Study design considerations for the Standardized Treatment Of Pulmonary exacerbations 2 (STOP2): a trial to compare intravenous antibiotic treatment durations in CF

BACKGROUND: Pulmonary exacerbations (PEx) in cystic fibrosis (CF) are common and contribute to morbidity and mortality. Duration of IV antibiotic therapy to treat PEx varies widely in the US, and there are few data to guide treatment decisions. METHODS: We combined a survey of CF stakeholders with r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Contemp Clin Trials
Autors principals: Heltshe, Sonya L., West, Natalie E., VanDevanter, Donald R., Sanders, D. B., Beckett, Valeria V., Flume, Patrick A., Goss, Christopher H.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5742044/
https://ncbi.nlm.nih.gov/pubmed/29170074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.11.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!